The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Nationwide Building Society Half-year Report

20 Nov 2017 16:29

RNS Number : 0192X
Nationwide Building Society
20 November 2017
 

Publication of Supplement

 

The following supplement to a prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

Nationwide Building Society*

Supplement dated 20 November 2017 to the Base Prospectus dated 31 August 2017, prepared in connection with the U.S.$25,000,000,000 European Note Programme, to the Base Prospectus dated 28 July 2017, prepared in connection with the €45,000,000,000 Global Covered Bond Programme, and to the Base Prospectus dated 30 June 2017, prepared in connection with the U.S.$20,000,000,000 Senior and Subordinated Medium-Term Note Programme, each established by Nationwide Building Society.

 

To view the full document, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/0192X_-2017-11-20.pdf

 

Interim Results

 

http://www.rns-pdf.londonstockexchange.com/rns/0192X_1-2017-11-20.pdf

 

A copy of the Supplement and the Interim Results will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/nsm.

 

For further information, please contact

 

Nationwide Building Society

One Threadneedle Street

London EC2R 8AW

 

Telephone: 0845 602 9053

 

*LEI: 549300XFX12G42QIKN82

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Base Prospectuses (as supplemented by the Supplement) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectuses) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectuses is not addressed. Prior to relying on the information contained in the Base Prospectuses you must ascertain from the Base Prospectuses whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PSPEAKFEAAFXFFF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.